Staphylococcus aureus is a frequent cause of primary or secondary bacteremia. It is also responsible for many cases of infective endocarditis, for which the therapeutic management is specific. The frequency of infective endocarditis among Staphylococcus aureus bacteremias varies between 2.7% and 23.4%. Many factors associated with the risk of developing endocarditis in patients with S. aureus bacteremia have been described. Two parameters of potential interest remain excluded from this work: blood culture growth time, a marker of bacterial inoculum, and the presence of bacteriuria, which is common during bacteremia. The objective of this study is to evaluate the interest of these two parameters in the prediction of the presence of endocarditis during S. aureus bacteremia. Investigators will conduct a retrospective study including all patients managed for Staphylococcus aureus bacteremia and in whom a urine culture was performed. The primary objective is to describe the factors associated with the occurrence of endocarditis in patients managed for S. aureus bacteremia and who received a urine cytobacteriological examination (UCE). The secondary objectives are: to evaluate the factors associated with the occurrence of S. aureus bacteriuria in patients with S. aureus bacteremia and to evaluate the risk factors for mortality in patients managed for S. aureus bacteremia.
Study Type
OBSERVATIONAL
Enrollment
247
Groupe Hospitalier Paris Saint-Joseph
Paris, France
Factors associated with the occurrence of endocarditis
This outcome corresponds to the description of predictive factors for infective endocarditis in patients with S. aureus bacteremia.
Time frame: Month 1
Factors associated with the occurrence of S. aureus bacteriuria
This outcome corresponds to the comparison of patients with S. aureus bacteremia and same-germ bacteriuria to those without same-germ bacteriuria.
Time frame: Month 1
Risk factors for mortality
This outcome corresponds to the comparison of patients who died in the setting of their S. aureus bacteremia to surviving patients.
Time frame: Month 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.